Disease-modifying therapy in neurodegeneration

Layer 3 — Biologyin the Neurodegenerative Disease subtree

ASOs (tofersen for SOD1-ALS), gene therapy (AAV-aducanumab), tau-targeted antibodies, alpha-synuclein vaccines (PD03A); decades of failed trials inform current strategy.

Related concepts

Tree (graph-theoretic)

Explore Disease-modifying therapy in neurodegeneration on the interactive knowledge graph →